15,000 Shares in Humana Inc. (NYSE:HUM) Acquired by MUFG Securities EMEA plc

MUFG Securities EMEA plc bought a new position in shares of Humana Inc. (NYSE:HUM) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund bought 15,000 shares of the insurance provider’s stock, valued at approximately $6,867,000.

A number of other institutional investors also recently modified their holdings of the company. High Ground Investment Management LLP lifted its position in shares of Humana by 16.0% during the 4th quarter. High Ground Investment Management LLP now owns 160,297 shares of the insurance provider’s stock valued at $73,386,000 after acquiring an additional 22,080 shares during the period. Intech Investment Management LLC raised its holdings in shares of Humana by 46.2% in the fourth quarter. Intech Investment Management LLC now owns 42,287 shares of the insurance provider’s stock valued at $19,359,000 after purchasing an additional 13,356 shares during the last quarter. Nations Financial Group Inc. IA ADV raised its holdings in shares of Humana by 13.0% in the fourth quarter. Nations Financial Group Inc. IA ADV now owns 1,248 shares of the insurance provider’s stock valued at $571,000 after purchasing an additional 144 shares during the last quarter. Skopos Labs Inc. purchased a new stake in shares of Humana in the fourth quarter valued at about $312,000. Finally, Advisory Services Network LLC raised its holdings in shares of Humana by 271.8% in the fourth quarter. Advisory Services Network LLC now owns 3,963 shares of the insurance provider’s stock valued at $1,815,000 after purchasing an additional 2,897 shares during the last quarter. 92.38% of the stock is owned by institutional investors.

Humana Trading Down 0.8 %

NYSE:HUM traded down $2.92 during trading hours on Friday, hitting $349.30. The company had a trading volume of 1,583,481 shares, compared to its average volume of 1,637,297. The company has a market capitalization of $42.09 billion, a PE ratio of 21.75, a price-to-earnings-growth ratio of 2.03 and a beta of 0.50. The stock has a 50-day moving average price of $324.36 and a 200 day moving average price of $370.76. Humana Inc. has a 52 week low of $298.61 and a 52 week high of $530.54. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.67 and a quick ratio of 1.67.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, April 24th. The insurance provider reported $7.23 EPS for the quarter, beating analysts’ consensus estimates of $6.12 by $1.11. The firm had revenue of $29.61 billion for the quarter, compared to analysts’ expectations of $28.52 billion. Humana had a net margin of 1.82% and a return on equity of 17.76%. The company’s quarterly revenue was up 10.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $9.38 EPS. On average, equities research analysts predict that Humana Inc. will post 16.18 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.01%. The ex-dividend date of this dividend is Friday, June 28th. Humana’s dividend payout ratio is presently 22.04%.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on HUM shares. Wells Fargo & Company lowered their target price on shares of Humana from $413.00 to $350.00 and set an “overweight” rating for the company in a report on Monday, April 8th. Argus lowered shares of Humana from a “buy” rating to a “hold” rating in a research report on Wednesday, March 13th. Oppenheimer reduced their price target on shares of Humana from $415.00 to $370.00 and set an “outperform” rating for the company in a research report on Thursday, April 25th. Royal Bank of Canada reduced their price target on shares of Humana from $415.00 to $353.00 and set an “outperform” rating for the company in a research report on Thursday, April 25th. Finally, Raymond James assumed coverage on shares of Humana in a research report on Friday, March 22nd. They set a “market perform” rating for the company. Eleven research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to MarketBeat, Humana currently has a consensus rating of “Hold” and an average target price of $426.39.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.